NCT01381419View on ClinicalTrials.gov

First Time in Human Study (FTIH) With Positron Emission Tomography (PET)

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 20, 2008

Primary Completion Date

April 1, 2009

Study Completion Date

April 1, 2009

Conditions
Schizophrenia
Interventions
DRUG

GSK1144814

Single dose.

DRUG

GSK1144814

Single dose which may be split in up to three divided doses given 2 to 3 hours apart.

DRUG

GSK1144814

Single dose that may be split in up to three divided doses given 2 to 3 hours apart.

Trial Locations (1)

HA1 3UJ

GSK Investigational Site, Harrow

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY